Mandashi

FourJaw Manufacturing Analytics provides a machine-agnostic data analytics platform that aims to maximize machining productivity through data-driven manufacturing. The platform offers real-time visibility of the shop floor, enabling users to monitor each machine's status, identify unplanned downtime, and respond quickly, with cloud-based monitoring and analytics designed for small and medium-sized manufacturers.

Hero of Health is an online platform that empowers individuals with chronic illnesses to manage their health digitally. It promotes healthy aging by offering personalized lifestyle habit plans, healthy aging recipes, and meal plans, aiming to reverse chronic illnesses and enable users to live healthier, more enjoyable lives.

GitLife Biotech specializes in version control systems for synthetic biology, offering tools such as DNA-based biosecurity measures to enhance reproducibility, proof of ownership, and scale within the field.

Ferrio is a technology company specializing in automation solutions for businesses. Its platform focuses on streamlining sales processes, automating data collection from suppliers, managing API connections, and eliminating manual, time-consuming tasks to accelerate business growth.

Wild Hydrogen develops a clean technology platform that converts wet biogenic feedstocks, such as agricultural and food waste and plastics, into hydrogen and biomethane under pressure. The process captures carbon dioxide and produces biochar, enabling carbon-negative fuel outcomes. The company targets emission reductions in hard-to-abate industries by providing a scalable pathway to low-carbon hydrogen and biomethane. By upgrading wet wastes into high-yield energy carriers, Wild Hydrogen aims to decarbonize industrial applications while minimizing waste and generating valuable byproducts.

Superbio.ai is a software-based data science and machine learning agency.

RareCan is a company focused on accelerating research and improving outcomes for patients with rare forms of cancer by developing a direct-to-patient clinical trial platform that creates novel patient and data pipelines powered by proprietary technology, enabling quicker and cheaper access to the patients and data needed for precision medicine trials and supporting the faster development of new therapies while increasing the success rate of rare cancer trials.